Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

A. A. Mian; A. Metodieva; S. Badura; M. Khateb; N. Ruimi; Y. Najajreh; O. G. Ottmann; J. Mahajna; M. Ruthardt

BMC Cancer 2012 Volume 12

Researcher